Skip to content

Welcome to Discover Pharma! Today is : October 11, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Veeva Systems

  • Biotech & Pharma Business,Digital & Data

    Veeva acquires Copli and launches AI-powered content review platform

    Veeva Systems has acquired Copli and launched a new AI-powered [...]

    June 25, 2026
  • Digital & Data

    UCB adopts Veeva Safety Suite to unify global pharmacovigilance operations

    UCB has standardised its global pharmacovigilance operations on Veeva Safety [...]

    June 10, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Opinion & Events

    Veeva and OpenEvidence form long-term AI partnership to accelerate clinical trial access and drug discovery

    Veeva Systems and OpenEvidence have announced a long-term partnership to [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Pharmaceuticals and therapeutics

    Bristol Myers Squibb adopts Veeva Vault CRM with embedded AI

    Bristol Myers Squibb (BMS) has committed to Veeva Vault CRM [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Manufacturing & Supply Chain

    IQVIA and Veeva agree global clinical and commercial collaboration

    IQVIA and Veeva Systems have announced the resolution of all [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Accelerating R&D in pharma: Inside Veeva’s mission to cut time-to-patient

    Stephan Ohnmacht, VP of R&D Business Consulting at Veeva Systems, [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Opinion & Events

    How tech can drive human-centric change in pharma: Insights from Veeva’s Dr Werner Engelbrecht

    At a roundtable during the Veeva Summit being held in [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Novadip secures €10.4M to advance pivotal Phase 3 trial
    Categories: Advanced Therapies, Biotech & Pharma Business, Clinical & Regulatory, Research & Development, Therapeutic Areas
  • Telix to acquire ITM in $1.65BN radiopharmaceutical deal
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Andelyn to manufacture FDA-approved Fayuvi gene therapy for Sanfilippo syndrome
    Categories: Advanced Therapies, Biotech & Pharma Business, Central Nervous System, Clinical & Regulatory, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top